| Autor: |
Yupeng Lai, Bin Li, Jiaming Huang, Jingning Du, Mengli Yue, Xin Shen, Xingjiao Liu, Lingfeng Huang, Jiehua Lin, Aicheng Yang, Meiying Wang |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Lupus. 32(1) |
| ISSN: |
1477-0962 |
| Popis: |
Objectives Systemic lupus erythematosus (SLE) predominantly occurs in women of child-bearing age. Selecting drugs for pregnant SLE patients has always been a difficult choice. Although there have been several reports of safety of belimumab in SLE patients during pregnancy, the data are far from sufficient. Methods We report on 4 cases of belimumab exposure in pregnant SLE patients. We also summarized 6 case reports and case series which were previously published. Further, we compared the different outcomes among SLE patients and their babies who continued with belimumab during pregnancy with those who discontinued belimumab in early pregnancy. Results Two cases discontinued belimumab in the early pregnancy, while the other two received belimumab until the late pregnancy. All the four women tolerated belimumab. Newborns have all developed normally and continue without complications during 1 year of follow-up. Conclusion In this small case series, we found that belimumab was well tolerated in pregnant SLE patients. There were no safety signals for the mothers or their babies. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
